Probability of overall survival and relapse according to postremission therapy. After a median follow-up of 53 months for surviving patients, the probability of overall survival and relapse (from remission) are shown for patients having received either chemotherapy (n = 132), autologous transplant (n = 141), or allogeneic transplant (n = 103) as postremission therapy. Tx indicates transplantation.